P P Vakharia1,2,3, R Chopra1,2,3, R Sacotte1,2,3, N Patel1,2,3, S Immaneni1,2,3, T White4, R Kantor1,2,3, D Y Hsu1,2,3, E L Simpson5, J I Silverberg1,4. 1. Department of Dermatology, Feinberg School of Medicine at Northwestern University, Chicago, IL, 60611, U.S.A. 2. Department of Preventive Medicine, Feinberg School of Medicine at Northwestern University, Chicago, IL, 60611, U.S.A. 3. Department of Medical Social Sciences, Feinberg School of Medicine at Northwestern University, Chicago, IL, 60611, U.S.A. 4. Northwestern Medicine Multidisciplinary Eczema Center, Chicago, IL, U.S.A. 5. Department of Dermatology, Oregon Health & Science University, Portland, OR, U.S.A.
Abstract
BACKGROUND: Several patient-reported outcomes have been used to assess the burden of atopic dermatitis (AD). Some are disease specific, such as the Patient-Oriented Eczema Measure (POEM), while others pertain to itch, for example the numerical rating scale (NRS)-itch, ItchyQoL and 5-D itch, or dermatological disease in general, for example the Dermatology Life Quality Index (DLQI). Development of severity strata is essential for proper interpretability of these assessments. OBJECTIVES: To confirm previously developed strata for POEM, DLQI and raw ItchyQoL, and develop strata for the NRS-itch, mean ItchyQoL and 5-D itch scale for use in adults with AD. METHODS: Self-administered questionnaires were completed by 210 adults with AD in a dermatology practice setting. Strata were selected using an anchoring approach based on patient-reported disease severity. RESULTS: We confirmed the existing strata for POEM (mild 0-7, moderate 8-16, severe 17-28; κ = 0·440), DLQI (mild 0-5, moderate 6-10, severe 11-30; κ = 0·398) and NRS-itch (mild 0-3, moderate 4-6, severe 7-10; κ = 0·499). However, the preferred band for raw ItchyQoL was mild 22-58, moderate 59-74 and severe 75-110 (κ = 0·379) and for mean ItchyQoL, mild 1-2·9, moderate 3·0-3·9, severe 4·0-5·0 (κ = 0·374). The preferred band for 5-D itch scale was mild 0-11, moderate 12-17 and severe 18-25 (κ = 0·331). CONCLUSIONS: Existing strata for POEM and DLQI performed well in adult AD. Previously reported strata for visual analogue scale-itch performed best for NRS-itch. We identified banding for the raw ItchyQoL for our AD population that varies slightly from the banding published for a more heterogeneous population. Finally, we proposed strata for mean ItchyQoL and 5-D itch scale in adult AD.
BACKGROUND: Several patient-reported outcomes have been used to assess the burden of atopic dermatitis (AD). Some are disease specific, such as the Patient-Oriented Eczema Measure (POEM), while others pertain to itch, for example the numerical rating scale (NRS)-itch, ItchyQoL and 5-D itch, or dermatological disease in general, for example the Dermatology Life Quality Index (DLQI). Development of severity strata is essential for proper interpretability of these assessments. OBJECTIVES: To confirm previously developed strata for POEM, DLQI and raw ItchyQoL, and develop strata for the NRS-itch, mean ItchyQoL and 5-D itch scale for use in adults with AD. METHODS: Self-administered questionnaires were completed by 210 adults with AD in a dermatology practice setting. Strata were selected using an anchoring approach based on patient-reported disease severity. RESULTS: We confirmed the existing strata for POEM (mild 0-7, moderate 8-16, severe 17-28; κ = 0·440), DLQI (mild 0-5, moderate 6-10, severe 11-30; κ = 0·398) and NRS-itch (mild 0-3, moderate 4-6, severe 7-10; κ = 0·499). However, the preferred band for raw ItchyQoL was mild 22-58, moderate 59-74 and severe 75-110 (κ = 0·379) and for mean ItchyQoL, mild 1-2·9, moderate 3·0-3·9, severe 4·0-5·0 (κ = 0·374). The preferred band for 5-D itch scale was mild 0-11, moderate 12-17 and severe 18-25 (κ = 0·331). CONCLUSIONS: Existing strata for POEM and DLQI performed well in adult AD. Previously reported strata for visual analogue scale-itch performed best for NRS-itch. We identified banding for the raw ItchyQoL for our AD population that varies slightly from the banding published for a more heterogeneous population. Finally, we proposed strata for mean ItchyQoL and 5-D itch scale in adult AD.
Authors: I M Haeck; O ten Berge; S G A van Velsen; M S de Bruin-Weller; C A F M Bruijnzeel-Koomen; M J Knol Journal: J Eur Acad Dermatol Venereol Date: 2011-03-24 Impact factor: 6.166
Authors: Nisha S Desai; Gabriele B Poindexter; Yvette Miller Monthrope; Sandra E Bendeck; Robert A Swerlick; Suephy C Chen Journal: J Am Acad Dermatol Date: 2008-06-11 Impact factor: 11.527
Authors: P I Spuls; L A A Gerbens; E Simpson; C J Apfelbacher; J R Chalmers; K S Thomas; C A C Prinsen; L B von Kobyletzki; J A Singh; H C Williams; J Schmitt Journal: Br J Dermatol Date: 2017-03-02 Impact factor: 9.302
Authors: P P Vakharia; R Chopra; R Sacotte; N Patel; S Immaneni; T White; R Kantor; D Y Hsu; J I Silverberg Journal: Allergy Date: 2017-10-09 Impact factor: 13.146
Authors: Jerry Bagel; Tien Q Nguyen; Hermenio Lima; Neal Jain; David M Pariser; Sylvia Hsu; Gil Yosipovitch; Haixin Zhang; Jingdong Chao; Shikha Bansal; Zhen Chen; Daniel Richman; Andrew Korotzer; Marius Ardeleanu Journal: Dermatol Ther (Heidelb) Date: 2022-05-20
Authors: Jonathan I Silverberg; Eric L Simpson; Mark Boguniewicz; Marjolein S De Bruin-Weller; Peter Foley; Yoko Kataoka; Gaëlle Bégo-Le-Bagousse; Zhen Chen; Brad Shumel; Jingdong Chao; Ana B Rossi Journal: Acta Derm Venereol Date: 2021-11-10 Impact factor: 3.875
Authors: Lawrence F Eichenfield; April Armstrong; Emma Guttman-Yassky; Peter A Lio; Chi-Chang Chen; Dionne M Hines; Catherine B McGuiness; Sohini Ganguli; Dimittri Delevry; Debra Sierka; Usha G Mallya Journal: Dermatol Ther (Heidelb) Date: 2022-05-11
Authors: Lisa A Beck; Diamant Thaçi; Mette Deleuran; Andrew Blauvelt; Robert Bissonnette; Marjolein de Bruin-Weller; Michihiro Hide; Lawrence Sher; Iftikhar Hussain; Zhen Chen; Faisal A Khokhar; Bethany Beazley; Marcella Ruddy; Naimish Patel; Neil M H Graham; Marius Ardeleanu; Brad Shumel Journal: Am J Clin Dermatol Date: 2020-08 Impact factor: 7.403
Authors: A B Kimball; J J Crowley; K Papp; B Calimlim; Y Duan; A B Fleischer; J Sobell Journal: J Eur Acad Dermatol Venereol Date: 2020-03-01 Impact factor: 6.166
Authors: J I Silverberg; D Lei; M Yousaf; S R Janmohamed; P P Vakharia; R Chopra; R Chavda; S Gabriel; K R Patel; V Singam; R Kantor; D Y Hsu Journal: Br J Dermatol Date: 2020-09-21 Impact factor: 9.302
Authors: J I Silverberg; D Lei; M Yousaf; S R Janmohamed; P P Vakharia; R Chopra; R Chavda; S Gabriel; K R Patel; V Singam; R Kantor; D Y Hsu Journal: J Eur Acad Dermatol Venereol Date: 2020-09-01 Impact factor: 6.166
Authors: Trisha Kaundinya; Uros Rakita; Armaan Guraya; Donna Maria Abboud; Emily Croce; Jacob P Thyssen; Andrew Alexis; Jonathan I Silverberg Journal: J Invest Dermatol Date: 2021-08-02 Impact factor: 8.551